From the first launch to ongoing market access operational execution, IntegriChain solves some of the most complex and pressing challenges associated with drug commercialization. We deliver pharma’s only comprehensive data, consulting, and business process platform for market access departments, providing the strategy, data, applications, and infrastructure for therapy commercialization.
Solutions overview
IntegriChain delivers the pharmaceutical industry’s largest and only data and business process platform for therapy commercialization and access. Manufacturers rely on our analytics, applications, and managed services to power their operations and harness the value of their channel, patient and payer data.
View all products
IntegriChain provides a complete set of professional services for commercialization and market access execution–from life science strategy and operational consulting to implementation, integration, migrations, and analytics.
Services overview
We help all stakeholders in the pharmaceutical industry drive access with our relentless focus on unifying all of the critical business functions for therapy commercialization and access – contracts & pricing, gross-to-net, channel, and patient services – to unlock strategic payer, provider, pharmacy and patient access insights.
Learn more about our company
Learn more about joining our growing IntegriChain team of data scientists, market access experts, analysts, and consulting professionals – our culture, our purpose, our teams in the US and Pune. Check out our careers or keep in touch for future opportunities.
Careers overview
Business Type
Top-10 pharmaceutical company
Functional Area
Contract Analysis and Administration
Challenge
The manufacturer felt that there was a disconnect between the contract negotiation business function and the contract analysis business function. The belief was that contract performance was not living up to the contract expectations determined at the onset of the agreement. The manufacturer requested that we help determine if its investment was optimized by applying our Rational Pricing methodology to its pricing process.
Business Challenges
Solution
We analyzed more than two years of data for two highly promoted brands from a combination of 16 strategic PBMs and/or HMOs within the managed care market. We were provided with internal data from the administrative systems, and we loaded it into our business tool. Our software identified any gaps and inconsistencies and then analyzed the data from a performance perspective.
Results
As a result of our gap analysis, we were able to identify non-performing and marginally performing investments that were not generating the expected ROI. We also assisted the manufacturer in profiling the accounts under review to determine an optimum and rational price for each account.
Key Takeaways
